###begin article-title 0
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras</italic>
Oncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells
###end article-title 0
###begin p 1
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRAS</italic>
###xml 126 130 126 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRAS</italic>
###xml 331 335 331 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 327 335 327 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 496 500 496 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 492 500 492 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 635 639 635 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 631 639 631 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 723 727 723 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 719 727 719 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 856 860 856 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 852 860 852 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 959 965 959 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 1076 1080 1076 1080 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1072 1080 1072 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 197 202 <span type="species:ncbi:9606">human</span>
###xml 418 424 <span type="species:ncbi:10090">murine</span>
###xml 1081 1085 <span type="species:ncbi:10090">mice</span>
How oncogenes modulate the self-renewal properties of cancer-initiating cells is incompletely understood. Activating KRAS and NRAS mutations are among the most common oncogenic lesions detected in human cancer, and occur in myeloproliferative disorders (MPDs) and leukemias. We investigated the effects of expressing oncogenic KrasG12D from its endogenous locus on the proliferation and tumor-initiating properties of murine hematopoietic stem and progenitor cells. MPD could be initiated by KrasG12D expression in a highly restricted population enriched for hematopoietic stem cells (HSCs), but not in common myeloid progenitors. KrasG12D HSCs demonstrated a marked in vivo competitive advantage over wild-type cells. KrasG12D expression also increased the fraction of proliferating HSCs and reduced the overall size of this compartment. Transplanted KrasG12D HSCs efficiently initiated acute T-lineage leukemia/lymphoma, which was associated with secondary Notch1 mutations in thymocytes. We conclude that MPD-initiating activity is restricted to the HSC compartment in KrasG12D mice, and that distinct self-renewing populations with cooperating mutations emerge during cancer progression.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 176 179 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAS</italic>
###xml 295 298 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 225 230 <span type="species:ncbi:9606">human</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 370 376 <span type="species:ncbi:9606">humans</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
###xml 935 939 <span type="species:ncbi:10090">mice</span>
Ras proteins act as molecular switches that relay growth signals from outside the cell. This mechanism is often subverted in cancer, and Ras proteins are activated directly by RAS gene mutations in approximately one-third of human malignancies. We have modeled this in mice engineered to have a Ras mutation. These mice develop a disease similar to chronic leukemias in humans called myeloproliferative disorders. It is marked by a fatal accumulation of mature and immature cells in the blood and bone marrow. We investigated whether some or all of these neoplastic cells were immortal. In agreement with the "cancer stem cell" hypothesis, we found that immortal cells were extremely rare in the bone marrow of diseased mice. They were found only in the same cell populations that contain normal bone marrow stem cells. However, these cells had high rates of replication and produced large numbers of daughter cells. Furthermore, many mice went on to develop acute lymphoid leukemia after acquiring additional mutations in maturing lymphoid cells. These studies exemplify the evolution of malignant stem cells during cancer progression. They also highlight the importance of rare, long-lived cells in the genesis and, potentially, therapy of high-risk chronic leukemias caused by abnormal Ras proteins.
###end p 4
###begin p 5
###xml 7 11 7 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 3 11 3 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 152 156 152 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 148 156 148 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
TheKrasG12D oncogene causes excessive proliferation of stem cells, promoting their preferential expansion and initiating myeloproliferative disease.KrasG12D does not alter self-renewal, but secondary mutations in lymphoid progenitors allow progression to acute leukemia.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 53 54 53 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b001">1</xref>
###xml 661 662 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b002">2</xref>
###xml 1030 1033 1030 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLL</italic>
###xml 1153 1154 1153 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b003">3</xref>
###xml 1155 1156 1155 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b004">4</xref>
###xml 1192 1196 1192 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JunB</italic>
###xml 1292 1293 1292 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b005">5</xref>
###xml 1059 1064 <span type="species:ncbi:9606">human</span>
###xml 1104 1110 <span type="species:ncbi:10090">murine</span>
###xml 1439 1444 <span type="species:ncbi:9606">human</span>
Self-renewal is integral to the malignant phenotype [1]. In principle, the ability of cancer cells to self-renew may be intrinsic to the compartment in which the tumor-initiating mutation occurs, or may be acquired as a consequence of mutations in more differentiated cells. The hematopoietic system has proven highly informative for addressing how cancer-associated mutations and cell of origin interact to establish malignant self-renewing populations. Accumulating evidence supports the idea that many hematopoietic malignancies exist in a hierarchy of differentiation with only a minor population capable of propagating and maintaining the disease in vivo [2]. These cells are termed leukemia-initiating cells or leukemia stem cells (LSCs), and manifest some biologic properties of normal hematopoietic stem cells (HSCs). However, the precise relationship between these populations is uncertain and appears to depend, in part, on both the leukemia subtype and on the effects of specific mutations. For example, overexpressing MLL fusion proteins found in human acute myeloid leukemia transforms both murine HSCs and more differentiated progenitors [3,4]. By contrast, inactivation of the JunB transcription factor must occur in the HSC compartment for initiation of myeloid malignancies [5]. These proof-of-concept experiments underscore the importance of understanding how oncogenes and tumor suppressors that are commonly mutated in human cancers perturb self-renewal and growth control. Importantly, the functional characteristics of LSCs that distinguish them from HSCs and how these properties are modulated by oncogenes are poorly understood.
###end p 7
###begin p 8
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAS</italic>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b006">6</xref>
###xml 227 230 227 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAS</italic>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRAS</italic>
###xml 314 318 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HRAS</italic>
###xml 363 367 351 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRAS</italic>
###xml 405 409 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRAS</italic>
###xml 411 412 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b006">6</xref>
###xml 433 436 421 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAS</italic>
###xml 653 654 641 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b007">7</xref>
###xml 879 880 867 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b008">8</xref>
RAS gene mutations are highly prevalent in pancreatic (>80%), colorectal (40%-50%), endometrial (40%), lung (30%), and cervical cancers (20%-30%), as well as in myeloid malignancies (20%-40%) [6]. Of the genes in the canonical RAS family, KRAS accounts for approximately90% of cancer-associated mutations, whereas HRAS mutations are rare. In hematologic cancers, NRAS is mutated 2-3 times more often than KRAS [6]. Cancer-associated RAS mutations, which introduce amino acid substitutions at codons 12, 13, or 61, result in oncogenic Ras proteins that accumulate in the active, GTP-bound conformation because of defective guanine nucleotide hydrolysis [7]. Elevated levels of GTP-bound Ras, in turn, deregulate signaling in cancer cells by altering the activation of effector cascades that include the Raf/MEK/ERK, phosphatidylinositol 3-kinase (PI3K)/Akt, and Ral-GDS pathways [8].
###end p 8
###begin p 9
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b009">9</xref>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRAS</italic>
###xml 453 457 453 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRAS</italic>
###xml 517 519 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b010">10</xref>
###xml 520 522 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b011">11</xref>
###xml 581 597 557 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRAS, NRAS, NF1,</italic>
###xml 601 607 577 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN11</italic>
###xml 622 624 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b012">12</xref>
###xml 744 747 720 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 751 757 727 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN11</italic>
###xml 885 887 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b012">12</xref>
###xml 941 950 917 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf1, Kras</italic>
###xml 956 962 932 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptpn11</italic>
###xml 1031 1033 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b013">13</xref>
###xml 1034 1036 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b016">16</xref>
###xml 1119 1126 1095 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL</italic>
###xml 1188 1192 1164 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JAK2</italic>
###xml 1268 1270 1244 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b017">17</xref>
###xml 554 562 <span type="species:ncbi:9606">patients</span>
###xml 708 716 <span type="species:ncbi:9606">children</span>
###xml 970 974 <span type="species:ncbi:10090">mice</span>
Chronic and juvenile myelomonocytic leukemias (CMML and JMML) are aggressive myeloid malignancies that are classified as myeloproliferative disorders (MPDs) [9]. Both diseases are characterized by leukocytosis with excess monocytes in blood and bone marrow, and by significant infiltration of malignant myeloid cells into the liver, spleen, and other organs. Hyperactive Ras is strongly implicated in the pathogenesis of JMML and CMML. Somatic NRAS and KRAS mutations are found in approximately40% of CMML specimens [10,11], and approximately85% of JMML patients have mutations in KRAS, NRAS, NF1, or PTPN11 (reviewed in [12]). The latter two genes encode proteins that regulate Ras-GTP levels. Importantly, children with germline mutations in NF1 or PTPN11 are at markedly increased risk of developing JMML, which argues strongly that deregulated Ras signaling can initiate this MPD [12]. This hypothesis is further supported by studies of Nf1, Kras, and Ptpn11 mutant mice, all of which develop MPDs that resemble JMML and CMML [13-16]. Mutations that alter other signaling molecules also cause MPD. For example, the BCR-ABL fusion gene is the hallmark of chronic myeloid leukemia, and JAK2 mutations are found in nearly all cases of polycythemia vera (reviewed in [17]). While mutations affecting signaling molecules are found in nearly all types of MPD, additional cooperating mutations are rare. MPDs are therefore genetically straightforward and tractable malignancies for understanding how aberrant signal transduction contributes to cancer by perturbation of stem and progenitor cell fates.
###end p 9
###begin p 10
###xml 30 34 30 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 26 34 26 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b013">13</xref>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b014">14</xref>
###xml 252 260 252 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 239 260 239 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup></italic>
###xml 428 432 428 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 424 432 424 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 476 484 476 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 463 484 463 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup></italic>
###xml 530 534 530 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 526 534 526 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 555 563 555 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 542 563 542 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup></italic>
###xml 649 653 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras</italic>
###xml 775 779 775 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 771 779 771 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 843 847 843 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 839 847 839 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 968 972 968 972 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 964 972 964 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 1325 1329 1325 1329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1321 1329 1321 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 1438 1444 1438 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
###xml 564 568 <span type="species:ncbi:10090">mice</span>
Mice expressing oncogenic KrasG12D in hematopoietic cells develop a fatal MPD with 100% penetrance that is characterized by leukocytosis, splenomegaly, and anemia, with death at approximately 3 mo of age [13,14]. In this system, injecting Mx1-Cre, KrasLSL-G12D mice with polyinosinic-polycytidylic acid (pIpC) induces expression of Cre recombinase, which removes an inhibitory loxP-STOP-loxP (LSL) element and activates the KrasG12D allele (we hereafter refer to Mx1-Cre, KrasLSL-G12D mice that have been treated with pIpC as KrasG12D mice). Mx1-Cre, KrasLSL-G12D mice provide a robust experimental system for investigating how expressing oncogenic Kras from the endogenous promoter affects HSCs and their progeny in vivo. Here, we identify tumor initiating cells in the KrasG12D model of MPD and find that, unlike some myeloid oncogenes, KrasG12D does not confer aberrant self-renewal properties to committed progenitor cells. However, small numbers of primitive KrasG12D cells can initiate MPD. This population shows excessive proliferation and rapidly dominates multilineage hematopoiesis in vivo. These data indicate that hyperactive Ras signaling is sufficient for the competitive advantage demonstrated by mutant HSCs and further implicate the HSC compartment as critical for therapy of JMML and CMML. Transplanted KrasG12D HSCs efficiently initiate T lineage acute lymphoblastic leukemia/lymphoma (T-ALL), which is associated with Notch1 mutations and with acquisition of LSC activity in differentiating thymocytes. These results further demonstrate that distinct self-renewing populations can arise through cooperating oncogenic mutations during cancer progression.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 12 16 12 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 8 16 8 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 115 123 115 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 102 123 102 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup></italic>
###xml 124 128 <span type="species:ncbi:10090">Mice</span>
A Small KrasG12D Population Dominates Both Primitive and Differentiated Hematopoietic Compartments in Mx1-Cre, KrasLSL-G12D Mice
###end title 12
###begin p 13
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre</italic>
###xml 40 42 40 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b018">18</xref>
###xml 43 45 43 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b019">19</xref>
###xml 66 74 66 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 53 74 53 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup></italic>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b014">14</xref>
###xml 247 251 247 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 243 251 243 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 430 438 430 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 417 438 417 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup></italic>
###xml 784 792 784 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g001">Figure 1</xref>
###xml 856 864 856 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 843 864 843 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup></italic>
###xml 883 889 883 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ROSA26</italic>
###xml 940 948 940 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g001">Figure 1</xref>
###xml 952 954 952 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b020">20</xref>
###xml 1138 1140 1138 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b018">18</xref>
###xml 1141 1143 1141 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b019">19</xref>
###xml 1243 1251 1243 1251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 1230 1263 1230 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup>, ROSA26-YFP</italic>
###xml 1357 1358 1357 1358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1362 1366 1362 1366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 1371 1372 1371 1372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1378 1379 1378 1379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1385 1386 1385 1386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1440 1442 1440 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b021">21</xref>
###xml 1496 1500 1496 1500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1492 1500 1492 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 1570 1571 1570 1571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1632 1636 1632 1636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1628 1636 1628 1636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 1676 1684 1676 1684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 1663 1684 1663 1684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup></italic>
###xml 1691 1699 1691 1699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g001">Figure 1</xref>
###xml 1808 1816 1808 1816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 1795 1816 1795 1816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup></italic>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 865 869 <span type="species:ncbi:10090">mice</span>
###xml 966 970 <span type="species:ncbi:10090">mice</span>
###xml 1073 1077 <span type="species:ncbi:10090">mice</span>
###xml 1264 1268 <span type="species:ncbi:10090">mice</span>
###xml 1685 1689 <span type="species:ncbi:10090">mice</span>
###xml 1817 1821 <span type="species:ncbi:10090">mice</span>
Although basal Mx1-Cre activity is low [18,19], many Mx1-Cre, KrasLSL-G12D mice that are not injected with pIpC ultimately succumb with MPD ([14] and unpublished data). This observation suggests that HSCs and/or progenitor cells that activate KrasG12D expression have a substantial proliferative advantage in vivo. To assess the kinetics of this process, we analyzed recombination in the myeloid progenitors of young Mx1-Cre, KrasLSL-G12D mice that were not treated with pIpC. Bone marrow cells from 3-5-wk-old animals were plated in methylcellulose medium to enumerate granulocyte-macrophage colony forming unit progenitors (CFU-GM), and individual myeloid colonies were genotyped by PCR. Surprisingly, nearly all CFU-GM in untreated animals were recombined as early as 3 wk of age (Figure 1A). We then examined more primitive populations in Mx1-Cre, KrasLSL-G12D mice crossed to a ROSA26 yellow fluorescent protein (YFP) reporter strain (Figure 1B) [20]. In these mice, cells expressing Cre are identified by YFP expression. The frequency of YFP+ cells in wild-type (WT) mice was within the expected range of background Cre expression [18,19]. However, we found a much higher incidence of YFP expression in bone marrow cells of Mx1-Cre, KrasLSL-G12D, ROSA26-YFP mice. This result was consistent among all populations analyzed, including the primitive Flk2- Lin-/lo Sca1+ c-kit+ (Flk2- LSK) compartment, which is highly enriched for HSCs [21]. To confirm that YFP expression correlated with KrasG12D expression, we also directly genotyped colonies formed by single Flk2- LSK cells. This method again revealed a predominance of KrasG12D-expressing cells in naive Mx1-Cre, KrasLSL-G12D mice (Figure 1C). Together, these data are consistent with an advantage for Cre-expressing cells in untreated Mx1-Cre, KrasLSL-G12D mice.
###end p 13
###begin title 14
###xml 16 20 16 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 12 20 12 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 69 77 69 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 56 77 56 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup></italic>
###xml 78 82 <span type="species:ncbi:10090">Mice</span>
Spontaneous KrasG12D Activation in CFU-GM and HSCs from Mx1-Cre, KrasLSL-G12D Mice
###end title 14
###begin p 15
###xml 309 312 309 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
(A) Bone marrow was harvested at 24 d or 5 wk of life from mice that either received a single dose of pIpC at 21 d of life or were left untreated, and plated in methylcellulose medium with GM-CSF. Individual colonies were isolated and genotyped by PCR to assess for Cre-mediated excision of the LSL cassette (n = 18 colonies from two uninjected animals, and 34 colonies from two injected animals, compiled from two independent experiments; error bars show SEM).
###end p 15
###begin p 16
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre</italic>
###xml 43 51 43 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 30 51 30 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup></italic>
###xml 87 94 87 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-YFP</italic>
###xml 219 222 219 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL</italic>
###xml 296 297 296 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 340 341 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 347 348 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 353 354 353 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 400 401 400 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 445 448 445 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 479 487 479 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 466 487 466 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup></italic>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
(B) Mx1-Cre (filled bars) and Mx1-Cre, KrasLSL-G12D (open bars) mice that inherited an LSL-YFP reporter were sacrificed at 5 wk of life, without ever being injected with pIpC. Expression of YFP requires excision of the LSL cassette from the reporter gene by Cre recombinase. The percentage of YFP+ cells in all bone marrow cells (Bulk), Lin- c-kit+ Sca1- myeloid progenitors (MP), LSK cells, and Flk2- LSK cells was assessed by flow cytometry. (n = 4 for WT and for Mx1-Cre, KrasLSL-G12D mice compiled from three independent experiments; error bars show SEM).
###end p 16
###begin p 17
###xml 8 9 8 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 74 82 74 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 61 82 61 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup></italic>
###xml 226 229 226 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
(C) Flk2- LSK cells were sorted from bone marrow of 4-wk-old Mx1-Cre, KrasLSL-G12D mice that had not received pIpC, and plated in methylcellulose medium for a culture period of 14 d. Individual colonies were genotyped by PCR (n = 44 colonies from 6 mice in 3 independent experiments; error bar shows SEM).
###end p 17
###begin title 18
###xml 34 38 34 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
Increased Cell Cycle Entry of KrasG12D HSCs
###end title 18
###begin p 19
###xml 30 34 30 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 26 34 26 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 111 115 111 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 107 115 107 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 250 254 250 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 246 254 246 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 521 522 521 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 540 544 540 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 536 544 536 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 630 638 630 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g002">Figure 2</xref>
###xml 644 645 644 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g002">2</xref>
###xml 665 666 665 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 719 720 719 720 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 750 754 750 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 746 754 746 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 759 760 759 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 942 943 942 943 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 963 967 963 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 959 967 959 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 985 989 985 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 981 989 981 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 994 995 994 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1056 1064 1056 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g002">Figure 2</xref>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
The apparent outgrowth of KrasG12D Flk2- LSK cells in mice that were not injected with pIpC suggested that KrasG12D expression might increase proliferation in this compartment. To test this hypothesis, we stained bone marrow cells collected from KrasG12D mice and WT littermates 2 wk after pIpC treatment with antibodies to cell surface proteins and with dyes that stain DNA and RNA (7-aminoactinomycin D [7-AAD] and pyronin Y, respectively). These studies revealed a significant reduction in the number of quiescent Flk2- LSK cells in KrasG12D animals, which are identified by having a 2n DNA content and low pyronin Y staining (Figure 2A and 2B). Whereas the Flk2- subset of WT LSK contains roughly 80% cells in the G0 phase of the cell cycle, KrasG12D Flk2- LSK are only 50% quiescent. As an initial exploration of mechanisms regulating cell cycle progression, we analyzed D- and E-type cyclin expression by quantitative PCR in sorted Flk2- LSK cells from KrasG12D and WT mice. KrasG12D Flk2- LSK cells had significantly higher expression of cyclin D1 (Figure 2C).
###end p 19
###begin title 20
###xml 31 35 31 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 27 35 27 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
Increased Proliferation of KrasG12D HSC
###end title 20
###begin p 21
###xml 37 41 37 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 33 41 33 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 154 155 154 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Bone marrow from 5-wk-old WT and KrasG12D mice was stained with 7-AAD and pyronin Y (PY) for DNA and RNA quantitation, along with surface markers for Flk2- LSK cells.
###end p 21
###begin p 22
###xml 58 62 58 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 54 62 54 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 67 68 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
(A) Gating is shown for cell cycle analysis of WT and KrasG12D Flk2- LSK cells.
###end p 22
###begin p 23
###xml 66 70 66 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 62 70 62 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 92 95 92 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 180 181 180 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 198 199 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 218 219 214 215 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 245 249 239 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 241 249 235 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 252 253 246 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 270 271 262 263 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 290 291 280 281 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 309 310 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 330 331 318 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 357 360 345 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p &lt;</italic>
###xml 372 375 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p &lt;</italic>
###xml 385 388 373 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p &lt;</italic>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
(B) Summary of replicate samples from WT (closed circles) and KrasG12D (open circles) mice (n = 3 or 4 as shown; compiled from two independent experiments). Means and SEM are WT: G0 81.8 +/- 4.72, G1 5.66 +/- 1.76, S-G2-M 11.7 +/- 2.56; and KrasG12D: G0 43.6 +/- 3.19, G1 34.9 +/- 4.85, S-G2-M 21.4 +/- 3.14. p-Values by unpaired t-test are indicated: ***, p < 0.001; **, p < 0.01; *, p < 0.05.
###end p 23
###begin p 24
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 143 146 143 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 261 262 261 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 592 601 589 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-1000059-sg001">Figure S1</xref>
(C) RNA from doubly sorted Flk2- LSK cells was isolated, and quantitative PCR performed on cDNA to test expression levels of selected cyclins (n = 3 or 4 as shown; bar shows geometric mean). Results are expressed as fold change in expression compared to WT Flk2- LSK cells, after normalization to beta-actin expression. These results represent three or four independent experiments as shown, each performed with pooled bone marrow from three to five animals. The geometric mean of cyclin D1 expression is 2.4-fold over WT (95% confidence interval 1.2-4.9). Purity of sorted cells is shown in Figure S1.
###end p 24
###begin title 25
###xml 67 71 67 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 63 71 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 72 76 <span type="species:ncbi:10090">Mice</span>
Self-Renewal Is Restricted to Primitive Hematopoietic Cells in KrasG12D Mice
###end title 25
###begin p 26
###xml 39 43 39 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b012">12</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b014">14</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b022">22</xref>
###xml 447 451 447 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 456 457 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 463 464 463 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 469 470 469 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 485 486 481 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 510 514 506 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 506 514 502 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 629 630 625 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 865 869 861 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 861 869 857 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 940 941 936 937 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sub>
###xml 994 998 990 994 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 990 998 986 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 1011 1019 1007 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g003">Figure 3</xref>
###xml 1118 1122 1114 1118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1114 1122 1110 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 1162 1170 1158 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g003">Figure 3</xref>
###xml 1176 1177 1172 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g003">3</xref>
###xml 1216 1218 1212 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b023">23</xref>
###xml 1219 1221 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b024">24</xref>
###xml 1228 1232 1224 1228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1224 1232 1220 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 1392 1396 1388 1392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1388 1396 1384 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 1449 1453 1445 1449 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1445 1453 1441 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 1532 1533 1528 1529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1553 1557 1549 1553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1549 1557 1545 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 1663 1667 1659 1663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1659 1667 1655 1663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 1776 1777 1772 1773 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1877 1881 1873 1877 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1873 1881 1869 1877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 1935 1943 1931 1939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g004">Figure 4</xref>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
Bone marrow mononuclear cells from KrasG12D mice display a hypersensitive pattern of CFU-GM progenitor growth, which is a cellular hallmark of JMML [12-14]. We found that this abnormal CFU-GM activity resides primarily in the common myeloid progenitor (CMP) compartment, and that these cells demonstrate enhanced proliferation in vivo ([22] and unpublished data). To investigate if this population could initiate and maintain MPD, we collected Lin-/lo Sca1- c-kit+ CD34+ FcgammaRII/III- CMPs from 5-wk-old KrasG12D mice and WT littermates by FACS, and transferred 10,000 of these cells into lethally irradiated recipients with 106 WT marrow cells for radioprotective support. Transplanted tester cells, recipient cells, and support cells were marked by expression of different isoforms of CD45, allowing them to be distinguished by flow cytometry. Transplanted KrasG12D or WT CMPs demonstrated robust day 8 spleen colony-forming unit (CFU-S8) activity, with colony size somewhat larger for KrasG12D input CMPs (Figure 3A). However, we detected less than 0.1% of circulating myeloid cells derived from transplanted KrasG12D or WT CMPs 1 mo after transplantation (Figure 3B and 3C). As expected from previous studies [23,24], KrasG12D and WT CMPs made minor contributions to the circulating B cell compartment with a statistically insignificant trend towards greater B cell production from KrasG12D cells. Taken together, these data indicate that KrasG12D CMPs do not initiate a hematologic disease. By contrast, transferring 500 Flk2- LSK cells from KrasG12D animals into lethally irradiated recipients rapidly resulted in durable multilineage reconstitution. KrasG12D cells dominated the T cell and B cell compartments sooner and to a higher degree than the progeny of WT Flk2- LSK cells in control animals. The myeloid series demonstrated a more variable time course, but KrasG12D derived cells also eventually out-competed WT cells (Figure 4).
###end p 26
###begin title 27
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
KrasG12D Does Not Lead to CMP Self-Renewal
###end title 27
###begin p 28
Sorted CD45.1 CMPs were transplanted into lethally irradiated CD45.2 recipients.
###end p 28
###begin p 29
###xml 36 37 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sub>
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 90 94 90 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 86 94 86 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
(A) Spleens were harvested for CFU-S8 colony analysis 8 d after transplantation of 104KrasG12D or WT CMPs. Gross images and hematoxylin/eosin stained sections are shown.
###end p 29
###begin p 30
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 78 82 78 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 74 82 74 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 107 108 107 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
(B) Peripheral blood of animals analyzed 1 mo after transplantation of 104KrasG12D or WT CMPs along with 106 CD45.1/CD45.2 heterozygous nucleated bone marrow cells for radioprotection (Support). Costaining with surface markers allowed detection of contributions to myeloid (purple), B (blue), and T (black) lineages.
###end p 30
###begin p 31
###xml 149 153 149 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 145 153 145 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
(C) Percentages of CMP-derived progeny within the indicated lineages found in peripheral blood 1 mo after transplantation of WT (filled bars) or KrasG12D (open bars) CMPs (n = 4 in two independent sorts).
###end p 31
###begin title 32
###xml 17 21 17 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 13 21 13 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 26 27 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
Transplanted KrasG12D Flk2- LSK Cells Outperform WT LSK Cells in Competitive Reconstitution
###end title 32
###begin p 33
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 101 105 101 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 97 105 97 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 117 118 117 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 238 242 238 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 234 242 234 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 496 500 496 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 492 500 492 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
Lethally irradiated recipients (n = 4 in a single experiment) were transplanted with 500 each of KrasG12D and WT Flk2- LSK cells, then bled monthly until sacrifice. Graphs show the proportion of graft-derived cells that came from the KrasG12D donor in circulating (A) T cell (CD3/CD5+), (B) B cell (B220+), and (C) myeloid (Mac1/Gr1+) populations. This was calculated by (1) gating for graft-derived cells (CD45.1 and CD45.1/CD45.2) within a lineage, and then (2) determining the fraction of KrasG12D-derived cells (CD45.1) within this subset.
###end p 33
###begin p 34
###xml 18 22 18 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 14 22 14 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 198 206 198 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g005">Figure 5</xref>
###xml 270 274 270 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 266 274 266 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 279 280 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 427 431 427 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 423 431 423 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 436 437 436 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 525 533 525 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 512 533 512 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup></italic>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b013">13</xref>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b014">14</xref>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
Recipients of KrasG12D Flk2- LSK cells that were euthanized 3 mo after transplantation had mild to moderate MPD, manifested as leukocytosis and splenomegaly with myeloid and erythroid infiltration (Figure 5). As discussed below, we also found that all recipients of KrasG12D Flk2- LSK cells developed T-ALL 2-4 mo after adoptive transfer. Although early mortality from T-ALL precluded analyzing recipient mice beyond 3 mo, KrasG12D Flk2- LSK cells recapitulate the essential features of MPD seen in the original Mx1-Cre, KrasLSL-G12D model [13,14].
###end p 34
###begin title 35
###xml 17 21 17 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 13 21 13 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 26 27 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
Transplanted KrasG12D Flk2- LSK Cells Induce MPD
###end title 35
###begin p 36
###xml 62 66 62 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 58 66 58 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 77 78 77 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 110 113 110 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 120 123 120 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 130 134 130 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 126 134 126 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were analyzed 3 mo after transplantation with either KrasG12D or WT Flk2- LSK cells for evidence of MPD (n = 3 WT, n = 6 KrasG12D in a single experiment).
###end p 36
###begin p 37
(A) Numbers of circulating leukocytes (WBC).
###end p 37
###begin p 38
(B) Spleen weights.
###end p 38
###begin p 39
(C) Percentages of myeloid cells (Mac1+ and/or Gr1+) in the spleen.
###end p 39
###begin p 40
(D) Percentages of erythroid precursors (nucleated and TER119+) in the spleen.
###end p 40
###begin p 41
(E) A representative splenic section demonstrating infiltration by mature myeloid cells (ring-shaped nuclei) and erythroblasts (small dense nuclei).
###end p 41
###begin title 42
###xml 30 34 30 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 26 34 26 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 35 39 <span type="species:ncbi:10090">Mice</span>
HSCs Are Less Frequent in KrasG12D Mice but Have Enhanced Repopulating Ability
###end title 42
###begin p 43
###xml 22 26 22 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 18 26 18 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 142 143 142 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 161 165 161 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 157 165 157 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 198 206 198 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g006">Figure 6</xref>
###xml 271 272 271 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 312 313 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 352 361 352 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-1000059-sg002">Figure S2</xref>
###xml 564 568 564 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 560 568 560 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 726 727 726 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 946 950 946 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 942 950 942 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 999 1007 999 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g006">Figure 6</xref>
###xml 1010 1018 1010 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-1000059-st001">Table S1</xref>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
We next asked how KrasG12D expression affects HSC function. Immunophenotypic analysis revealed a 2-fold reduction in the number of marrow Flk2- LSK cells in KrasG12D mice 2 wk after pIpC injection (Figure 6A). This was mostly offset by an increased number of splenic Flk2- LSK cells. The reduction in marrow Flk2- LSK cells persisted in older animals (Figure S2). We also performed limit dilution studies to assess functional HSC activity. In these experiments, lethally irradiated recipients received decreasing numbers of whole bone marrow cells from either KrasG12D mice or WT littermates that had been injected with pIpC 2 wk earlier. Recipients were bled monthly, and flow cytometry was performed to assess whether CD45.1+ donor cells were able to provide durable (>2 mo) multilineage (myeloid, B cell, and T cell) engraftment. These studies demonstrated a striking 10-fold decrease in the number of long-term repopulating stem cells in KrasG12D animals compared to the WT littermate controls (Figure 6B; Table S1).
###end p 43
###begin title 44
###xml 45 49 45 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 41 49 41 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 50 54 <span type="species:ncbi:10090">Mice</span>
HSC Number and Proliferative Capacity in KrasG12D Mice
###end title 44
###begin p 45
###xml 26 30 26 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 22 30 22 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
HSCs were analyzed in KrasG12D mice or WT littermates that were treated with pIpC at 21 d of age and then sacrificed at 35 d of age.
###end p 45
###begin p 46
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 44 48 44 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 40 48 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 141 144 141 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p &lt;</italic>
###xml 152 153 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p &lt;</italic>
###xml 231 234 231 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 242 245 242 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 361 362 361 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b075">75</xref>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
(A) Total numbers of Flk2- LSK cells in KrasG12D mice (open bars) or WT mice (filled bars) were quantified by flow cytometry in bone marrow (p < 0.001, t-test) and spleen (p < 0.01); total numbers (spleen + marrow) are also shown (p = 0.12). n = 6 mice per genotype, and error bars show SEM; data are pooled from two independent experiments. Frequencies of Flk2- LSK cells among viable nucleated cells were multiplied by nucleated bone marrow cell counts in femurs and tibias and then scaled to estimate total bone marrow numbers using published distributions [75].
###end p 46
###begin p 47
###xml 31 35 31 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 27 35 27 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 317 321 317 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 313 321 313 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 441 445 441 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 437 445 437 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 476 480 476 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 472 480 472 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 521 524 521 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 546 547 546 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 607 615 607 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-1000059-st001">Table S1</xref>
(B) Whole bone marrow from KrasG12D (open circles) or WT littermates (filled circles) was tested for repopulating activity in a limit dilution transplantation assay. The calculated values for frequencies of repopulating units were 1 in 16,610 nucleated bone marrow cells (NMBC) for WT marrow and 1 in 180,404 for KrasG12D marrow. Narrow lines designate 95% confidence intervals (1:7,338 to 1:37,598 for WT and 1:68,953 to 1: 471,998 for KrasG12D; frequencies in WT versus KrasG12D marrow are significantly different with p = 0.0003 by two-tailed t-test). Outcomes of individual experiments are described in Table S1.
###end p 47
###begin p 48
###xml 102 103 102 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 118 119 118 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 128 132 128 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 124 132 124 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 362 365 362 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 409 413 409 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 405 413 405 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 422 425 422 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 4 8 <span type="species:ncbi:10090">Mice</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 390 394 <span type="species:ncbi:10090">mice</span>
(C) Mice that engrafted after transplantation with limiting numbers of whole bone marrow cells (1 x 104 for WT, 1 x 105 for KrasG12D) were bled at 2 mo to determine the percentage of circulating myeloid (Mac1/Gr1+), B-lineage (B220+), and T-lineage (CD3/CD5+) cells that were derived from the transplanted marrow. Filled bars represent mice receiving WT marrow (n = 2), open bars represent mice receiving KrasG12D marrow (n = 3; error bars show SEM; note logarithmic scale).
###end p 48
###begin p 49
###xml 135 139 135 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 131 139 131 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 233 237 233 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 229 237 229 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 302 303 302 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 307 311 307 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 303 311 303 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 322 323 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 602 606 578 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 598 606 574 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 699 707 675 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g006">Figure 6</xref>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
Progression of MPD despite a reduction in the size of the HSC compartment suggests an increased production of mature cells by each KrasG12D HSC. To address this possibility, we examined the patterns of reconstitution from either KrasG12D or WT HSCs in mice that received the limit dilution dose (1 x 105KrasG12D and 1 x 104 WT bone marrow cells). As approximately50% of these recipients were engrafted with donor cells, the Poisson distribution predicts that approximately 70% of the engrafting mice received a single HSC and approximately24% received two HSC. By 2 mo after transplantation, donor KrasG12D marrow cells made a markedly greater contribution to recipient hematopoiesis than WT cells (Figure 6C).
###end p 49
###begin p 50
###xml 80 84 80 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 76 84 76 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 268 272 268 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 264 272 264 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 309 310 309 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 335 336 335 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 503 507 503 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 499 507 499 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 520 521 520 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 641 645 641 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 637 645 637 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 658 659 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 718 727 718 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-1000059-sg003">Figure S3</xref>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
We were able to compare repopulation of the stem cell compartment by WT and KrasG12D HSCs in a few lethally irradiated recipient mice before the onset of T-ALL. In these experiments, lethally irradiated recipients (CD45.2) were reconstituted with equal numbers of KrasG12D (CD45.1) and WT (CD45.1/CD45.2) Flk2- LSK cells, as well as 106 CD45.2 whole bone marrow cells (CD45.2) for radioprotection. Whereas only one of six recipients euthanized 2 mo after transplantation showed a clear bias towards KrasG12D-derived Flk2- LSK cells, mice that survived for 3 mo without evidence of diffuse T-ALL demonstrated an overwhelming bias towards KrasG12D-derived Flk2- LSK cells, myeloid progenitors, and mature myeloid cells (Figure S3).
###end p 50
###begin title 51
###xml 35 39 35 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 31 39 31 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 80 86 80 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
T-ALL Arises from Transplanted KrasG12D HSCs in Thymocytes That Acquire Somatic Notch1 Mutations
###end title 51
###begin p 52
###xml 39 43 39 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 48 49 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 400 408 400 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g007">Figure 7</xref>
###xml 542 546 542 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 538 546 538 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 649 653 649 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 645 653 645 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 658 659 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
Recipients that were injected with KrasG12D Flk2- LSK cells, either alone or in a 1:1 ratio with WT Flk2- LSK cells, uniformly became moribund 8-14 wk after transplantation. Examination of euthanized mice revealed massive thymic enlargement with an arrest in T cell development at the CD4/CD8 double positive stage, and variable infiltration of blast cells within the liver, spleen, and bone marrow (Figure 7A). Importantly, two of three animals from the bone marrow limit dilution transplantation assay that were engrafted with a single KrasG12D repopulating unit developed T-ALL that was identical to that seen in animals repopulated with 500 KrasG12D Flk2- LSK cells (unpublished data).
###end p 52
###begin title 53
###xml 17 21 17 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 13 21 13 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 26 27 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
Transplanted KrasG12D Flk2- LSK Cells Initiate T-ALLs That Contain Notch1 Mutations
###end title 53
###begin p 54
###xml 75 79 75 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 71 79 71 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
(A) Flow cytometry of thymocytes harvested from moribund recipients of KrasG12D Flk2- LSK cells shows an abnormal accumulation of CD4/CD8 double positive and immature CD8 single positive cells. Spleen histology demonstrates infiltration by monomorphic cells with open chromatin (hematoxylin/eosin).
###end p 54
###begin p 55
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 48 52 48 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 44 52 44 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 57 58 57 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 111 112 111 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 220 221 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 436 440 436 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 432 440 432 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b013">13</xref>
###xml 347 352 <span type="species:ncbi:10090">mouse</span>
(B) Primary recipients (n = 5) received 500 KrasG12D Flk2- LSK cells with or without an equal number of WT Flk2- LSK cells after lethal irradiation (950 rad). These primary recipients were euthanized 2-3 mo later, and 106 bone marrow cells or thymocytes were transferred into sublethally irradiated (450 rad) secondary recipients (two per primary mouse). Sublethal irradiation selectively permits transfer of acute leukemia but not KrasG12D HSCs or MPD [13]. Thymocytes, but not bone marrow cells, transferred T-ALL.
###end p 55
###begin p 56
###xml 107 111 107 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 103 111 103 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 306 312 306 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 367 371 367 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 363 371 363 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
(C) Cell lysates from thymocytes and bone marrow of animals euthanized 3 mo after transplantation with KrasG12D or WT HSCs were blotted with an antibody specific for cleaved Notch1. Three independent primary recipients are shown. Sequence analysis demonstrates frameshift mutations near the PEST domain of Notch1 in thymocytes from five of six mice that received KrasG12D HSC, but not in recipients receiving WT HSCs alone (reference sequence from GenBank [] accession number NM_008714).
###end p 56
###begin p 57
###xml 97 101 97 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 93 101 93 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 243 247 243 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 239 247 239 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b013">13</xref>
###xml 479 483 479 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 475 483 475 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 488 489 488 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 601 609 601 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g007">Figure 7</xref>
###xml 899 903 899 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 895 903 895 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
###xml 1025 1029 <span type="species:ncbi:10090">mice</span>
Next, we asked if T-ALL arose within the bone marrow or the thymus of mice transplanted with KrasG12D HSCs. To do this, we took advantage of our prior observation that recipients conditioned with sublethal irradiation fail to engraft with KrasG12D bone marrow [13]. Therefore, sublethally irradiated recipients can exclusively select for hematologic malignancies with more aggressive biologic behavior. We isolated bone marrow cells and thymocytes from primary recipients of KrasG12D Flk2- LSK cells that developed T-ALL, and injected each population into sublethally irradiated secondary recipients (Figure 7B). As expected, no animals demonstrated multilineage engraftment or MPD. Animals transplanted with thymocytes quickly succumbed with an identical T-ALL as primary recipients; however, none of the mice transplanted with bone marrow developed leukemia. Thus, whereas bone marrow-derived KrasG12D HSCs efficiently give rise to T-ALL, the T-ALL LSC population is initially restricted to the thymus in primary recipient mice.
###end p 57
###begin p 58
###xml 119 125 119 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH1</italic>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b025">25</xref>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b028">28</xref>
###xml 259 263 259 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 255 263 255 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 471 479 471 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g007">Figure 7</xref>
###xml 634 640 634 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 702 706 702 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 698 706 698 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 711 712 711 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 880 886 880 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 150 155 <span type="species:ncbi:9606">human</span>
###xml 160 166 <span type="species:ncbi:10090">murine</span>
###xml 789 793 <span type="species:ncbi:10090">mice</span>
These results suggested that one or more secondary mutations might have developed in a novel T-lymphoid clone. Somatic NOTCH1 mutations are common in human and murine T-ALL [25-28]. To determine if a similar mechanism might contribute to the evolution of KrasG12D HSCs to T-ALL LSCs, we performed Western blot analysis to detect cleaved (activated) Notch1 protein. Cleaved Notch1 was observed in thymocytes from diseased primary recipients, but not in bone marrow cells (Figure 7C), a finding that is consistent with the secondary transplant data. Direct sequencing around the PEST domain uncovered frameshift mutations in exon 34 of Notch1 in thymocytes from five of six animals transplanted with KrasG12D Flk2- LSK cells that developed T-ALL, but no mutations in thymocytes from control mice that received WT HSCs alone and remained well. The presence of a somatically acquired Notch1 mutation in a large fraction of the tumor provides a molecular indication of clonality.
###end p 58
###begin title 59
###xml 28 32 28 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 24 32 24 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 33 37 <span type="species:ncbi:10090">Mice</span>
Thymic Abnormalities in KrasG12D Mice
###end title 59
###begin p 60
###xml 22 26 22 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 18 26 18 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 91 95 91 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 87 95 87 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 195 196 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 201 202 201 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 213 214 209 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 220 223 216 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 228 231 224 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 261 269 257 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g008">Figure 8</xref>
###xml 273 275 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b029">29</xref>
###xml 291 295 287 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 287 295 283 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 423 431 419 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g008">Figure 8</xref>
###xml 698 706 694 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g008">Figure 8</xref>
###xml 842 846 838 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras</italic>
###xml 860 868 856 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g008">Figure 8</xref>
###xml 924 928 920 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 920 928 916 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
###xml 854 858 <span type="species:ncbi:10090">mice</span>
The propensity of KrasG12D HSCs to generate T-ALL led us to investigate the effects of KrasG12D expression in early T-lineage cells. Flow cytometry of the bone marrow revealed no expansion of Lin- Flk2+ IL-7Ralpha+ c-kitint Sca1int common lymphoid progenitors (Figure 8A) [29]. However, KrasG12D mice demonstrated consistent thymic enlargement compared to age-matched littermate controls, even prior to the onset of T-ALL (Figure 8B). Immunophenotyping of primary thymocytes demonstrated an essentially normal distribution of CD4+ and CD8+ expression, with a slight trend toward an increased number of CD4/CD8 double negative (DN) cells (after excluding Mac1+ and Gr1+ infiltrating myeloid cells) (Figure 8B). By contrast, further examination of the DN compartment using the cell surface markers CD44 and CD25 uncovered skewed development in Kras mutant mice (Figure 8C). Together, these data demonstrate that oncogenic KrasG12D perturbs thymic homeostasis, particularly in early stages of thymocyte maturation.
###end p 60
###begin title 61
###xml 39 43 39 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 44 48 <span type="species:ncbi:10090">Mice</span>
Abnormal T-lymphoid Development in KrasG12D Mice
###end title 61
###begin p 62
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 28 29 28 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 40 41 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 47 50 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 55 58 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 123 127 119 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 119 127 115 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 308 309 304 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 358 361 354 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 377 381 373 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 373 381 369 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 463 464 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
(A) Enumeration of Lin- Flk2+ IL-7Ralpha+ c-kitint Sca1int common lymphoid progenitors (CLPs) in bone marrow of WT and KrasG12D mice. A typical comparison and gating strategy is shown, with the far right panel showing expression of c-kit and Sca1 in CLPs (black dots) compared to the larger population of Lin- cells (gray dots). CLP frequencies are graphed (n = 5 WT and 6 KrasG12D; error bars show SEM and difference is not statistically significant by unpaired t-test).
###end p 62
###begin p 63
###xml 35 39 35 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 31 39 31 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 162 165 162 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 213 216 213 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p &lt;</italic>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
(B) Enlarged thymi in 7-wk-old KrasG12D mice compared with WT littermates; photograph shows a typical example, and graph shows data from a representative cohort (n = 3 mice and error bars show standard deviation; p < 0.05).
###end p 63
###begin p 64
###xml 120 121 120 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 376 379 376 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 425 426 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
(C) Flow cytometry of primary thymocytes for expression of CD4 and CD8, and also CD25 and CD44 expression within DN (CD4- CD8-) cells; figure shows a representative example. Myeloid cells were excluded using Mac1 and Gr1 staining. Graph represents the frequency of thymocytes within in the live gate in DN, double positive (CD4+D8+, DP), and CD4 or CD8 single positive cells (n = 3 mice per genotype and error bars show SEM; p > 0.05 for all populations. Data are representative of three independent experiments).
###end p 64
###begin title 65
Discussion
###end title 65
###begin p 66
###xml 27 31 27 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 23 31 23 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 222 223 222 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 691 698 691 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL</italic>
###xml 725 729 725 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JunB</italic>
###xml 793 794 793 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b005">5</xref>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b030">30</xref>
###xml 973 974 973 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b003">3</xref>
###xml 975 976 975 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b004">4</xref>
###xml 1292 1294 1292 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b031">31</xref>
###xml 1295 1297 1295 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b032">32</xref>
###xml 661 667 <span type="species:ncbi:10090">murine</span>
We find that oncogenic KrasG12D expression in HSCs confers a strong in vivo growth advantage, increases proliferation, and results in MPD and T-ALL. In MPD, as in normal marrow, stem cell activity is restricted to the Flk2- LSK population, which represents less than 0.1% of nucleated marrow cells. While pathologic behaviors of more mature cells may contribute to tissue infiltration, anemia, and organomegaly, self-renewal is confined to this very primitive population. Therefore, hyperactive Ras signaling promotes excess proliferation in multiple hematopoietic compartments without immortalizing non-self-renewing cells. Similar data have been described in murine models of MPD based on BCR-ABL overexpression or loss of JunB, both of which also deregulate cytoplasmic signaling networks [5,30]. By contrast, recent experiments have provided direct evidence that some oncogenic transcription factors allow committed myeloid progenitors to acquire self-renewal ability [3,4]. Taken together, studies of myeloid oncogenes performed to date support the general idea that mutations that predominately alter cytoplasmic signaling networks and those that affect transcription factors controlling cell fate decisions comprise discrete complementation groups for the fully transformed phenotype [31,32].
###end p 66
###begin p 67
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras</italic>
###xml 270 274 270 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 266 274 266 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b033">33</xref>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b038">38</xref>
###xml 684 689 <span type="species:ncbi:9606">human</span>
###xml 690 698 <span type="species:ncbi:9606">patients</span>
Our limit dilution transplantation data demonstrate that oncogenic Kras confers a dramatic growth advantage in the HSC compartment. Under stringent conditions in which the contribution of a single WT HSC can barely be detected, the progeny of one (or at most three) KrasG12D HSC comprise a substantial fraction of the hematopoietic compartment. These studies provide direct experimental evidence that the outgrowth of malignant cells in MPD can be attributed to hyperactive Ras signaling in HSC. Our data suggest a pathogenic model in which JMML or CMML is initiated by a somatic mutation that deregulates Ras signaling in a single HSC. This idea is consistent with limited data from human patients and xenograft studies that implicate the HSC as the cell of origin for JMML [33-38].
###end p 67
###begin p 68
###xml 120 124 120 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 116 124 116 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 129 130 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 224 228 224 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 220 228 220 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b039">39</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b040">40</xref>
###xml 471 472 471 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 481 482 481 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b041">41</xref>
###xml 613 617 613 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 609 617 609 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b042">42</xref>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
To begin to address the mechanism by which mutant HSCs outgrow their WT counterparts, we analyzed the cell cycle in KrasG12D Flk2- LSK cells and found they are preferentially in cycle. The overexpression of cyclin D1 in KrasG12D cells we observed is consistent with many prior studies in cultured cell lines engineered to overexpress oncogenic Ras [39,40]. Intriguingly, HSCs in mice lacking D-type cyclins demonstrate severe proliferative defects and accumulate in the G0 and/or G1 phases of the cell cycle [41]. If increased cyclin D1 levels conversely result in excessive proliferation of HSC, then MPD in KrasG12D mice may be mediated in part by cyclin D1, similar to the requirement for cyclin D1 in a model of Ras-mediated breast cancer [42].
###end p 68
###begin p 69
###xml 77 81 77 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 73 81 73 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 326 329 326 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 322 329 322 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>&#8722;/&#8722;</sup></italic>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b043">43</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b044">44</xref>
###xml 432 436 432 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 428 436 428 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 489 493 489 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 485 493 485 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 579 580 579 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 708 712 708 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 704 712 704 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 851 855 851 855 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 847 855 847 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 1032 1036 1032 1036 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1028 1036 1028 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 1129 1133 1129 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRAS</italic>
###xml 1176 1178 1176 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b045">45</xref>
###xml 1266 1268 1266 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b046">46</xref>
###xml 1269 1271 1269 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b050">50</xref>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
###xml 713 717 <span type="species:ncbi:10090">mice</span>
We demonstrate a substantial early growth advantage of HSCs that express KrasG12D; however, it is also possible that oncogenic Ras expression has a negative long-term impact on HSC function. Increased proliferation or oncogenic stress may ultimately detract from self-renewal capacity. Reduced HSC fitness was observed in Pten-/- mice, in which phosphatidylinositol 3-kinase signaling is hyperactive [43,44]. Similar effects of KrasG12D are suggested by the reduced numbers of HSCs in KrasG12D mice, although this finding could also reflect changes in the composition of the Flk2- LSK population or cell-extrinsic effects related to alteration of the marrow microenvironment. The rapid demise of primary KrasG12D mice from MPD, and of transplant recipients from T-ALL, precluded serial transplantation experiments to test the long term fitness of KrasG12D HSC. In addition, the 5-fold discrepancy between HSC numbers that were measured by flow cytometry versus limit dilution transplantation suggests a defect in engraftment of KrasG12D HSC. This idea is consistent with a prior report in which retroviral transduction of mutant NRAS appeared to reduce engraftment potential [45], and with extensive data showing that proliferating HSCs fail to engraft efficiently [46-50].
###end p 69
###begin p 70
###xml 60 64 60 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 56 64 56 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 131 135 131 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 127 135 127 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 245 249 245 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 241 249 241 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 283 291 283 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 279 291 279 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>LSL-G12D</sup></italic>
###xml 332 339 332 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre</italic>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b051">51</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b052">52</xref>
###xml 467 471 467 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 463 471 463 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 511 512 511 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 706 710 706 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 702 710 702 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 850 854 850 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 846 854 846 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 711 715 <span type="species:ncbi:10090">mice</span>
Despite the reduced number of HSC in the bone marrow of KrasG12D mice, our data are not entirely consistent with the idea that KrasG12D is a cell-intrinsic negative regulator of HSC self-renewal. If it were, we would expect specific loss of KrasG12D cells and outgrowth of WT or KrasLSL-G12D cells, because conditional models using Mx1-Cre typically retain a small pool of cells with the unrearranged locus [51,52]. However, we observed preferential retention of KrasG12D cells, even within the diminishing Flk2- LSK compartment. This observation suggests that residual WT HSCs are unable to compensate for the reduced HSC number. Therefore, we favor the hypothesis that the reduction in HSC number in KrasG12D mice reflects a disordered bone marrow microenvironment with reduced supportive capacity rather than a purely cell-intrinsic effect of KrasG12D in HSC.
###end p 70
###begin p 71
###xml 72 76 72 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 68 76 68 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 121 125 121 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 117 125 117 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 212 216 212 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 208 216 208 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 256 264 256 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g005">Figure 5</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b013">13</xref>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b016">16</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b053">53</xref>
###xml 518 525 518 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre</italic>
###xml 565 569 565 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 561 569 561 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b054">54</xref>
###xml 795 803 795 803 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 782 803 782 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup></italic>
###xml 822 826 822 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 883 887 883 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 879 887 879 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 648 652 <span type="species:ncbi:10090">mice</span>
###xml 804 808 <span type="species:ncbi:10090">mice</span>
###xml 888 892 <span type="species:ncbi:10090">mice</span>
The natural history of hematologic disease was different in primary KrasG12D mice than in recipients of transplanted KrasG12D HSC. A subtle but important finding is that MPD is established earlier in primary KrasG12D mice than in transplanted recipients. (Figure 5 and [13]; also see [16,53]). There are several possible explanations for this observation. The hematopoietic microenvironment in young mice may be more permissive for MPD than the irradiated bone marrow of an adult. Additionally, pIpC administration in Mx1-Cre mice may quickly create a field of KrasG12D myeloid progenitors that contributes to the rapid evolution of MPD in primary mice through cytokine-mediated autocrine and/or paracrine mechanisms [54]. It is also possible that nonhematopoietic stromal cells in Mx1-Cre, KrasLSL-G12D mice express K-RasG12D and contribute to the rapid onset of MPD in primary KrasG12D mice.
###end p 71
###begin p 72
###xml 145 149 145 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 141 149 141 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 372 376 360 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 368 376 356 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 780 782 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b013">13</xref>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 859 863 <span type="species:ncbi:10090">mice</span>
The kinetics of MPD development relate directly to the high frequency of T-ALL we observed in transplanted recipients as compared to primary KrasG12D mice. The apparent incidence of T-ALL is highly subject to selection bias, because animals that die from MPD cannot be evaluated for subsequent emergence of T-ALL. For example, we have observed approximately10%-15% of KrasG12D mice develop T-ALL on an inbred C57BL/6 strain background (unpublished data), but median time to death from MPD is shorter than the typical latency of T-ALL, and lymphoid tumors exclusively appear in mice with a relatively late onset of MPD. Similarly, we have not observed spontaneous T-ALL in F1 (C57BL/6 x 129Sv/Jae) mice, which die from MPD at a younger age than the C57BL/6 strain described here ([13] and unpublished data). In transplant recipients, aggressive T-ALL arose in mice that also had evidence of underlying MPD that was not yet severe enough to kill the animal. Together, these observations suggest that the attenuation of MPD in transplant recipients was central to the apparent increase in the incidence of T-ALL in the transplant setting.
###end p 72
###begin p 73
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b055">55</xref>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b057">57</xref>
###xml 193 197 193 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 189 197 189 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 374 382 374 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 361 382 361 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup></italic>
###xml 422 426 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras</italic>
###xml 494 500 494 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 562 566 562 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 558 566 558 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
Cooperation of hyperactive Ras and deregulated Notch signaling in T-ALL has recently been shown [55-57]. Our data extend these studies by demonstrating the remarkable efficiency with which KrasG12D HSCs can initiate T-ALL, and delineating how multiple cell types may participate in the stepwise acquisition of oncogenic mutations in hematologic cancers. In the Mx1-Cre, KrasLSL-G12D model, T-ALL is initiated by oncogenic Kras expression in HSC, but full transformation occurs when cooperating Notch1 mutations arise in a T-lineage cell. In this sense, both KrasG12D HSCs and the fully transformed thymocytes can be considered different types of malignant stem cells with distinct leukemogenic potentials.
###end p 73
###begin p 74
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras</italic>
###xml 293 297 293 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 289 297 289 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b058">58</xref>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b059">59</xref>
###xml 462 466 462 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b060">60</xref>
###xml 803 807 803 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G13D</sup>
###xml 799 807 799 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRAS<sup>G13D</sup></italic>
###xml 832 836 832 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRAS</italic>
###xml 900 902 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b061">61</xref>
###xml 994 998 994 998 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 981 998 981 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>G12D</sup></italic>
###xml 1005 1007 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b056">56</xref>
###xml 1062 1066 1062 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 680 687 <span type="species:ncbi:9606">patient</span>
###xml 999 1003 <span type="species:ncbi:10090">mice</span>
One potential implication of these results is that the initiating Kras mutation creates conditions favorable for acquisition of cooperating mutations by increasing the size of susceptible lymphoid progenitor pools and/or conferring resistance to apoptotic signals during thymic selection. KrasG12D appears to most greatly affect the DN population that is characteristically undergoing TCR rearrangement, selection, and proliferation [58,59]. Interestingly, K-RasG12D protein expression may substitute for the pre-T cell receptor rearrangement at this critical checkpoint, thereby allowing propagation of thymocytes that would normally be edited [60]. Consistent with this idea, a patient with impaired lymphoid homeostasis and multiple lymphoid malignancies was recently reported to have a germline NRASG13D mutation, and oncogenic NRAS suppressed apoptosis of lymphocytes after cytokine withdrawal [61]. By contrast, Kindler et al. recently reported reduced thymic cellularity in Mx1-Cre, KrasG12D mice [56]. We speculate that the proliferative effects of K-RasG12D in the T cell compartment were obscured in those studies by the short interval between pIpC injection, which induces systemic interferon production, and histologic analysis.
###end p 74
###begin p 75
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b062">62</xref>
###xml 293 297 293 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 289 297 289 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 448 452 448 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 783 789 783 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH1</italic>
###xml 1020 1026 1020 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH1</italic>
###xml 1155 1161 1155 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH1</italic>
###xml 1171 1173 1171 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b063">63</xref>
###xml 14 22 <span type="species:ncbi:9606">patients</span>
###xml 102 110 <span type="species:ncbi:9606">patients</span>
###xml 995 1000 <span type="species:ncbi:9606">human</span>
###xml 1101 1109 <span type="species:ncbi:9606">patients</span>
The idea that patients may harbor a variety of genetically distinct LSC is consistent with studies of patients with chronic myeloid leukemia in blast transformation [62], and has important therapeutic implications. The need to eliminate partially transformed but self-renewing cells, like KrasG12D HSCs, will depend on their propensity to initiate a life-threatening disease. Targeted therapies that are directed against onco-proteins such as K-RasG12D will effectively eliminate premalignant clones only if the targeted lesions are initiating rather than secondary mutations. For example, inhibition of Notch signaling is an attractive therapeutic strategy for T-ALL that is being investigated in the clinic. However, if these cancers arise from aberrant HSCs that do not contain a NOTCH1 mutation and are not eradicated by treatment, relapse could occur through the acquisition of distinct cooperating mutations in a self-renewing preleukemic population. Consistent with this idea, studies of human T-ALL suggest that NOTCH1 mutation occurs as a secondary mutation in at least some cases, with some patients developing recurrent disease having distinct NOTCH1 alleles [63].
###end p 75
###begin p 76
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRAS</italic>
###xml 370 374 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras</italic>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b064">64</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b068">68</xref>
###xml 440 444 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras</italic>
###xml 577 580 577 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc</italic>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b068">68</xref>
###xml 685 689 685 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRAS</italic>
###xml 753 756 753 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC</italic>
###xml 786 788 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b069">69</xref>
###xml 789 791 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b071">71</xref>
###xml 813 817 813 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 809 817 809 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 901 903 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b072">72</xref>
###xml 1084 1088 1084 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRAS</italic>
###xml 1311 1315 1311 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras</italic>
###xml 199 204 <span type="species:ncbi:9606">human</span>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
###xml 495 501 <span type="species:ncbi:10090">murine</span>
###xml 652 657 <span type="species:ncbi:9606">human</span>
###xml 658 666 <span type="species:ncbi:9606">patients</span>
###xml 818 822 <span type="species:ncbi:10090">mice</span>
###xml 1422 1427 <span type="species:ncbi:9606">human</span>
Finally, our data have implications for understanding the nature of cancer stem cell populations in nonhematopoietic malignancies. KRAS is the most frequent target of dominant oncogenic mutations in human cancer, and it is particularly important in carcinomas of the lung, pancreas, and colon. Analogous cancers arise in strains of mice expressing conditional oncogenic Kras alleles in these tissues [64-68]. Importantly, whereas oncogenic Kras expression efficiently initiates tumorigenesis in murine lung and pancreas, colon cancer is observed only when the tumor suppressor Apc is inactivated as well [68]. These data are consistent with studies of human patients, which imply that KRAS mutation occurs early in pancreatic cancer but typically after APC mutation in colon carcinoma [69-71]. Lung cancer in KrasG12D mice appears to be initiated in a distinct bronchio-alveolar stem cell population [72]. On the basis of these observations and our data, we speculate that, like HSCs, cells initiating pancreatic and lung cancer will possess inherent self-renewal potential, and that KRAS mutations only contribute to colon tumorigenesis in cells that have already acquired a mutation that enhances self-renewal. Uncovering specific proteins and pathways that are essential for the self-renewal and survival of Kras mutant cancer stem cell populations may reveal novel targets for therapeutic intervention in a variety of human cancers.
###end p 76
###begin title 77
Materials and Methods
###end title 77
###begin title 78
Ethics statement.
###end title 78
###begin p 79
All animals were handled in strict accordance with good animal practice as defined by the relevant national and local animal welfare bodies, and all animal work was approved by the institutional animal research committee (University of California, San Francisco IACUC).
###end p 79
###begin title 80
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse strains.
###end title 80
###begin p 81
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b013">13</xref>
###xml 168 176 168 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 155 176 155 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1-Cre, Kras<sup>LSL-G12D</sup></italic>
###xml 221 235 220 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ROSA26 LSL-YFP</italic>
###xml 278 283 277 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptprc</italic>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
Animals were housed in a barrier facility at the University of California, San Francisco. All mice were of the C57BL/6 strain. As described [13], 21-d-old Mx1-Cre, KrasLSL-G12D were injected IP with 250 mug pIpC (Sigma). ROSA26 LSL-YFP reporter mice were a gift from C. Lowell. Ptprc (CD45) congenic mice were from Jackson Labs.
###end p 81
###begin title 82
Colony assays.
###end title 82
###begin p 83
###xml 48 49 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 240 241 240 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 467 471 461 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras</italic>
###xml 572 573 564 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 598 600 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b013">13</xref>
###xml 167 173 <span type="species:ncbi:10090">murine</span>
To assay CFU-GM, nucleated bone marrow cells (105) or splenocytes (2 x 105) were suspended in 1 ml methylcellulose medium (M3231, StemCell Technologies) with 10 ng/ml murine GM-CSF (PeproTech). Colonies were counted after 8 d. To assay Flk2- LSK cells, 100 sorted cells were plated in 1 ml methylcellulose medium (M3434, StemCell Technologies), which is provided containing IL-3, IL-6, stem cell factor, and erythropoietin, and incubated at 37 degreesC for 14 d. For Kras genotyping, individual colonies were picked with a 10 mul pipette and frozen overnight in 10 mul ddH2O prior to PCR analysis [13].
###end p 83
###begin title 84
Flow cytometry.
###end title 84
###begin p 85
###xml 43 45 43 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b021">21</xref>
###xml 46 48 46 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b024">24</xref>
###xml 204 208 198 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 213 214 207 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 220 221 214 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 226 227 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 243 247 237 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 252 253 246 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 259 260 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 265 266 259 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 275 276 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 626 627 616 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1103 1104 1088 1089 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1127 1128 1112 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 606 610 <span type="species:ncbi:9925">goat</span>
###xml 616 619 <span type="species:ncbi:10116">rat</span>
###xml 645 651 <span type="species:ncbi:10090">murine</span>
###xml 1542 1546 <span type="species:ncbi:10090">mice</span>
###xml 1705 1709 <span type="species:ncbi:10090">mice</span>
Flow cytometry was performed as described [21,24]. Staining was carried out in FACS Staining Buffer (FSB; HBSS with 2% heat inactivated FCS) at 0 degreesC unless otherwise stated. HSCs were defined as Lin-/lo Sca1+ c-kit+ Flk2-, and CMP as Lin-/lo Sca1- c-kit+ CD34+ FcgammaR-. Antibodies were from eBioscience except as specified. To identify HSCs, cells were first stained for 1 h with unconjugated lineage antibodies: CD3 (17A2, BioLegend); CD4 (RM4-5); CD5 (53-7.3); CD8 (53-6.7); B220 (RA3-6B2); Ter119 (TER-119); Mac1 (M1/70); Gr1 (RB6-8C5). Cells were washed then incubated for 30 min with TriColor goat-anti-rat F(ab')2 (Invitrogen) and murine IgG (Sigma). Cells were washed again, stained for 30 min with Pacific Blue anti-Sca1 (D7, BioLegend); APC anti-c-kit (2B8, BioLegend); PE anti-Flk2 (A2F10, BioLegend); and 7-AAD (Sigma) 5 mug/ml for dead cell exclusion. IL-7Ralpha was detected using a PE conjugate (eBioscience). In this case, or when analyzing YFP+ cells, Flk2 was detected with biotinylated anti-Flk2 and APC-Alexa Fluor 750 streptavidin (Invitrogen). We found no difference in Flk2- LSK staining when Mac1+ cells were identified an on independent channel but not excluded. For myeloid progenitor analysis, PE anti-Flk2 was replaced with PE anti-FcgammaRII/III (93) and FITC anti-CD34 (RAM34), and cells were stained for an additional 30 min prior to analysis. Mature cells were assigned lineage using Pacific Blue anti-Mac1 and anti-Gr1 (myeloid), FITC anti-CD3 and anti-CD5 (T), and PE anti-B220 (B). T cell subsets in mice with T-ALL were distinguished with Pacific Orange anti-CD4 (Invitrogen), APC anti-CD8, FITC anti-CD3, and PE anti-CD5. To discern origin of cells in chimeric mice, antibodies to CD45.1 (A20; PE-Cy7) and CD45.2 (104; Alexa Fluor 700) were added. Primary thymocytes were analyzed with PE-Cy7 anti-CD4, Alexa 647 anti-CD8, PE anti-CD25, Pacific Blue anti-CD44, and FITC anti-Mac1 and anti-Gr1.
###end p 85
###begin p 86
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Prior to sorting, c-kit+ cells were enriched with anti-CD117 microbeads and an AutoMACS (Miltenyi). Cell sorting was performed on a FACSAria and flow cytometry on an LSRII, both using FACSDiva software (BD). Data were analyzed using FlowJo software (TreeStar).
###end p 86
###begin title 87
Transplantation.
###end title 87
###begin p 88
###xml 234 238 <span type="species:ncbi:10090">mice</span>
Recipients received a single fraction of 950 rads for lethal irradiation, or 450 rads for sublethal irradiation, from a cesium source. Donor cells were prepared in 100 to 200 mul of FSB, and injected retro-orbitally into anesthetized mice. Recipients received water with neomycin and polymyxin for 2 wk. Blood counts were monitored monthly using a Hemavet 950FS (Drew Scientific).
###end p 88
###begin p 89
###xml 43 45 43 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b073">73</xref>
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 117 118 117 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 129 130 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 172 173 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
Limit dilution was performed as described [73]. Lethally irradiated recipients were transplanted with 1 x 104, 3 x 104, or 1 x 105 nucleated bone marrow cells along with 106 unfractionated WT bone marrow cells for radioprotection. Peripheral blood was analyzed monthly by flow cytometry; mice with detectable engraftment in myeloid, B and T lineages 2 mo after transplantation were scored as positive and L-Calc software (StemCell Technologies) was used for statistical analysis.
###end p 89
###begin p 90
###xml 13 14 13 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sub>
###xml 58 59 58 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
For the CFU-S8 assay, lethally irradiated mice received 105 CMPs without support cells. Spleen colonies were observed 8 d later by gross examination at harvest and after 48 h fixation in 10% formalin. Sections were stained with hematoxylin and eosin.
###end p 90
###begin title 91
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
Notch1 analysis.
###end title 91
###begin p 92
###xml 82 83 79 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 84 85 81 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 86 87 83 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sub>
###xml 96 97 93 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 99 100 96 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Cells were lysed in 1% NP-40 with 30 mM NaF, 30 mM beta-glycerophosphate, 20 mM Na4P2O7, 1 mM Na3VO4, and Complete (Roche) and analyzed after SDS-PAGE using cleaved Notch1 and beta-actin antibodies (Cell Signaling). Genomic DNA was PCR-amplified sequenced bidirectionally using 5'-ATAGCATGATGGGGCCACTA-3' and 5'-GCCTCTGGAATGTGGGTGAT-3'.
###end p 92
###begin title 93
Cell cycle analysis.
###end title 93
###begin p 94
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b074">74</xref>
###xml 977 978 973 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Staining with 7-AAD and pyronin Y was performed as described [74] in nucleic acid staining solution (NASS; 0.1M phosphate-citrate buffer [pH 6.0] [Sigma], 5mM EDTA, 0.15M NaCl, 0.5% BSA), with 0.02% saponin (Sigma). Nucleated bone marrow cells were stained for 30 min with FITC lineage antibodies (CD3, CD4, CD5, CD8, B220, Ter119, and Gr1), Pacific Blue anti-Sca1, unconjugated anti-CD16/32 (2.4G2, UCSF hybridoma core), and biotinylated anti-Flk2. Cells were washed and then stained with APC-Alexa Fluor 750 streptavidin. Cells were washed again and resuspended in 500 mul of NASS with 1 mug/ml 7-AAD (Sigma), and incubated at room temperature for 30 min, then on ice for 5 min. Pyronin Y (Sigma) was then added to 1 mug/ml, and cells were incubated for an additional 10 min before being washed and resuspended in 200 muL of FSB. Cells were finally stained with APC anti-c-kit and FITC anti-Mac1. Differences in the quiescent fraction of HSCs were analyzed using an unpaired t-test.
###end p 94
###begin title 95
Quantitative real-time PCR.
###end title 95
###begin p 96
###xml 38 40 38 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-1000059-b050">50</xref>
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 863 872 859 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-1000059-sg001">Figure S1</xref>
The assay was performed as described [50]. Flk2- KLS cells from animals pooled by genotype were double-sorted directly into RNA binding/lysis buffer from the RNEasy kit (Qiagen), and total RNA was extracted per instructions. First strand cDNA synthesis was performed using a SuperScript III kit (Invitrogen) per manufacturer's instructions. Reactions were performed in an ABI-7900 sequence detection system using SYBR green according to manufacturer's instructions (Applied Biosystems). Each amplification was performed in 10 mul with a template cDNA equivalent of 100 sorted HSCs. Each sample was tested in triplicate with each primer pair, and normalized to beta-actin expression. Due to limiting numbers of doubly sorted cells, final cell purity was not analyzed; however the staining characteristics of c-kit-enriched and singly sorted cells are presented in Figure S1.
###end p 96
###begin title 97
Poisson statistics.
###end title 97
###begin p 98
###xml 219 220 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 307 308 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 352 353 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</italic>
###xml 354 355 354 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 353 355 353 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;<italic>n</italic></sup>
###xml 381 382 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 560 561 560 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</italic>
###xml 567 568 567 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</italic>
###xml 568 573 568 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;ln 2</sup>
###xml 581 582 581 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</italic>
###xml 594 595 594 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</italic>
###xml 595 600 595 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;ln 2</sup>
###xml 610 611 610 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</italic>
###xml 627 628 627 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 628 629 628 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</italic>
###xml 629 634 629 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;ln 2</sup>
###xml 644 645 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</italic>
###xml 661 662 661 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 662 663 662 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</italic>
###xml 663 668 663 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;ln 2</sup>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 203 208 <span type="species:ncbi:10090">mouse</span>
###xml 276 281 <span type="species:ncbi:10090">mouse</span>
###xml 443 448 <span type="species:ncbi:10090">mouse</span>
###xml 521 526 <span type="species:ncbi:10090">mouse</span>
###xml 696 700 <span type="species:ncbi:10090">mice</span>
To analyze repopulation by a single HSC, we identified a cohort of mice receiving a cell dose yielding engraftment in only 50% of recipients. The Poisson distribution indicates that the probability of a mouse receiving k HSCs is given by where n is the average HSC number per mouse. The average that yields k = 0 HSC at a rate of 0.5 is given by 0.5 = e-n, which is solved to give n = 0.693. Using this value for the average number of HSC per mouse, the Poisson distribution can be used to estimate the likelihood of any mouse receiving a given number of HSC: f(0) = e-ln 2 = 0.5; f(1) = (ln 2)e-ln 2 = 0.346; f(2) = 1/2 (ln 2)2e-ln 2 = 0.120; f(3) = 1/6 (ln 2)3e-ln 2 = 0.028. The proportion of mice expected to receive four or more HSCs is the remainder, 1 - (0.5 + 0.346 + 0.12 + 0.028) = 0.006, or 0.6%. 
###end p 98
###begin title 99
Supporting Information
###end title 99
###begin title 100
Purity of Cells Sorted for RNA Purification
###end title 100
###begin p 101
###xml 169 173 169 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 165 173 165 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
Cells expressing c-kit were enriched by magnetic bead isolation, then doubly sorted by FACS. FACS data for the first and second sorts for typical examples of WT and KrasG12D mice are shown.
###end p 101
###begin p 102
(740 KB TIF)
###end p 102
###begin p 103
Click here for additional data file.
###end p 103
###begin title 104
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 38 42 38 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 34 42 34 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 43 47 <span type="species:ncbi:10090">Mice</span>
Flk2- LSK Cell Number in 8-wk-Old KrasG12D Mice
###end title 104
###begin p 105
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p &lt;</italic>
###xml 104 107 104 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 111 114 111 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p &lt;</italic>
###xml 149 153 149 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 145 153 145 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 191 199 191 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000059-g002">Figure 2</xref>
###xml 291 294 291 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 459 460 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
Flow cytometry was performed to enumerate Flk2- LSK cells in bone marrow (n = 4; p < 0.05) and spleens (n = 6; p < 0.05) harvested from 8-wk-old KrasG12D or WT mice. Data were analyzed as in Figure 2. Combined numbers in marrow and spleen were not significantly different between genotypes (p = 0.27). Data are pooled from two independent experiments; error bars show standard error of the mean (SEM). Statistical significance was evaluated with the unpaired t-test.
###end p 105
###begin p 106
(80 KB TIF)
###end p 106
###begin p 107
Click here for additional data file.
###end p 107
###begin title 108
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
KrasG12D HSCs Dominate the Stem Cell Compartment by 3 mo after Transplantation
###end title 108
###begin p 109
###xml 38 42 38 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 34 42 34 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 99 102 99 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 119 122 119 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 252 256 252 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 248 256 248 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 279 280 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 473 477 473 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 482 483 482 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 489 490 489 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 505 506 501 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice transplanted with 500 CD45.1 KrasG12D and 500 CD45.1/CD45.2 WT HSCs were sacrificed (A) 2 mo (n = 6) or (B) 3 mo (n = 2) after transplantation, and their chimerism was assessed by flow cytometry. The percentage of graft cells derived from the KrasG12D HSCs is shown for Flk2- LSK cells (black bars), CMPs (dark grey bars), granulocyte-macrophage progenitors (GMP, light grey bars), and mature (Mac1/Gr1+) circulating myeloid cells (open bars). GMPs were defined as Lin-/lo Sca1- c-kit+ FcgammaRII/III+. Animals lacking any graft-derived contribution to the HSC compartment have been omitted.
###end p 109
###begin p 110
(168 KB TIF)
###end p 110
###begin p 111
Click here for additional data file.
###end p 111
###begin title 112
Outcomes of Individual Limit Dilution Transplantation Experiments
###end title 112
###begin p 113
###xml 25 29 <span type="species:ncbi:10090">mice</span>
The indicated numbers of mice were transplanted with 10,000, 30,000, or 100,000 nucleated bone marrow cells, and the proportions with detectable multilineage engraftment were determined 2 mo later. The number of repopulating units was calculated using the totals from these four experiments with L-Calc software (StemCell Technologies).
###end p 113
###begin p 114
(47 KB PDF)
###end p 114
###begin p 115
Click here for additional data file.
###end p 115
###begin p 116
###xml 71 79 71 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-G12D</sup>
###xml 67 79 67 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>LSL-G12D</sup></italic>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
We thank David A. Tuveson and Tyler Jacks for generously providing KrasLSL-G12D mice.
###end p 116
###begin title 117
Abbreviations
###end title 117
###begin p 118
7-aminoactinomycin D
###end p 118
###begin p 119
granulocyte-macrophage colony forming unit
###end p 119
###begin p 120
day 8 spleen colony-forming unit
###end p 120
###begin p 121
chronic myelomonocytic leukemia
###end p 121
###begin p 122
common myeloid progenitor
###end p 122
###begin p 123
double negative
###end p 123
###begin p 124
hematopoietic stem cell
###end p 124
###begin p 125
juvenile myelomonocytic leukemia
###end p 125
###begin p 126
leukemia stem cell
###end p 126
###begin p 127
Lin-/lo Sca1+ c-kit+
###end p 127
###begin p 128
loxP-STOP-loxP
###end p 128
###begin p 129
myeloproliferative disorder
###end p 129
###begin p 130
polyinosinic-polycytidylic acid
###end p 130
###begin p 131
standard error of the mean
###end p 131
###begin p 132
T lineage acute lymphoblastic leukemia/lymphoma
###end p 132
###begin p 133
wild type
###end p 133
###begin p 134
yellow fluorescent protein
###end p 134
###begin title 135
References
###end title 135
###begin article-title 136
The hallmarks of cancer
###end article-title 136
###begin article-title 137
Acute myeloid leukemia stem cells
###end article-title 137
###begin article-title 138
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9
###end article-title 138
###begin article-title 139
Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors
###end article-title 139
###begin article-title 140
JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells
###end article-title 140
###begin article-title 141
Hyperactive Ras in developmental disorders and cancer
###end article-title 141
###begin article-title 142
GEFs and GAPs: critical elements in the control of small G proteins
###end article-title 142
###begin article-title 143
Targeting RAS signalling pathways in cancer therapy
###end article-title 143
###begin article-title 144
Focus on myeloproliferative diseases and myelodysplastic syndromes
###end article-title 144
###begin article-title 145
RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia
###end article-title 145
###begin article-title 146
###xml 107 115 <span type="species:ncbi:9606">patients</span>
Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients
###end article-title 146
###begin article-title 147
Inherited predispositions and hyperactive Ras in myeloid leukemogenesis
###end article-title 147
###begin article-title 148
Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder
###end article-title 148
###begin article-title 149
Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease
###end article-title 149
###begin article-title 150
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation
###end article-title 150
###begin article-title 151
Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder
###end article-title 151
###begin article-title 152
Oncogenes in myeloproliferative disorders
###end article-title 152
###begin article-title 153
###xml 28 32 <span type="species:ncbi:10090">mice</span>
Inducible gene targeting in mice
###end article-title 153
###begin article-title 154
Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity
###end article-title 154
###begin article-title 155
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
###end article-title 155
###begin article-title 156
Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells
###end article-title 156
###begin article-title 157
K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cells
###end article-title 157
###begin article-title 158
Fetal liver myelopoiesis occurs through distinct, prospectively isolatable progenitor subsets
###end article-title 158
###begin article-title 159
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
###end article-title 159
###begin article-title 160
###xml 34 39 <span type="species:ncbi:9606">human</span>
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
###end article-title 160
###begin article-title 161
###xml 62 68 <span type="species:ncbi:10090">murine</span>
Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma
###end article-title 161
###begin article-title 162
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
Activating Notch1 mutations in mouse models of T-ALL
###end article-title 162
###begin article-title 163
###xml 142 147 <span type="species:ncbi:10090">mouse</span>
Radiation-induced deletions in the 5' end region of Notch1 lead to the formation of truncated proteins and are involved in the development of mouse thymic lymphomas
###end article-title 163
###begin article-title 164
Flk2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages
###end article-title 164
###begin article-title 165
###xml 82 88 <span type="species:ncbi:10090">murine</span>
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors
###end article-title 165
###begin article-title 166
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
###end article-title 166
###begin article-title 167
The roles of FLT3 in hematopoiesis and leukemia
###end article-title 167
###begin article-title 168
###xml 49 57 <span type="species:ncbi:9606">children</span>
Patterns of hematopoietic lineage involvement in children with neurofibromatosis, type 1, and malignant myeloid disorders
###end article-title 168
###begin article-title 169
Evidence that juvenile myelomonocytic leukemia can arise from a pluripotential stem cell
###end article-title 169
###begin article-title 170
###xml 101 108 <span type="species:ncbi:9606">patient</span>
Development of two cytogenetically abnormal clones from multipotential hematopoietic stem cells in a patient with juvenile myelomonocytic leukemia
###end article-title 170
###begin article-title 171
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 82 90 <span type="species:ncbi:9606">patients</span>
Engraftment of NOD/SCID/gammac(null) mice with multilineage neoplastic cells from patients with juvenile myelomonocytic leukaemia
###end article-title 171
###begin article-title 172
Juvenile chronic myelogenous leukemia multilineage CD34+ cells: aberrant growth and differentiation properties
###end article-title 172
###begin article-title 173
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice
###end article-title 173
###begin article-title 174
How do small GTPase signal transduction pathways regulate cell cycle entry
###end article-title 174
###begin article-title 175
Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins
###end article-title 175
###begin article-title 176
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse development and cell proliferation in the absence of D-cyclins
###end article-title 176
###begin article-title 177
Specific protection against breast cancers by cyclin D1 ablation
###end article-title 177
###begin article-title 178
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
###end article-title 178
###begin article-title 179
PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention
###end article-title 179
###begin article-title 180
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice
###end article-title 180
###begin article-title 181
The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit
###end article-title 181
###begin article-title 182
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0)
###end article-title 182
###begin article-title 183
Homing and engraftment potential of Sca-1(+)lin(-) cells fractionated on the basis of adhesion molecule expression and position in cell cycle
###end article-title 183
###begin article-title 184
###xml 69 75 <span type="species:ncbi:10090">murine</span>
Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells
###end article-title 184
###begin article-title 185
Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates
###end article-title 185
###begin article-title 186
Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors
###end article-title 186
###begin article-title 187
Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival
###end article-title 187
###begin article-title 188
Quantitative effects of Nf1 inactivation on in vivo hematopoiesis
###end article-title 188
###begin article-title 189
Hyperactivation of protein kinase B and ERK have discrete effects on survival, proliferation, and cytokine expression in Nf1-deficient myeloid cells
###end article-title 189
###begin article-title 190
Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia
###end article-title 190
###begin article-title 191
K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors
###end article-title 191
###begin article-title 192
Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system
###end article-title 192
###begin article-title 193
In vivo dynamics of CD4-8- thymocytes. Proliferation, renewal and differentiation of different cell subsets studied by DNA biosynthetic labeling and surface antigen detection
###end article-title 193
###begin article-title 194
T cell receptor (TCR)-beta gene recombination: dissociation from cell cycle regulation and developmental progression during T cell ontogeny
###end article-title 194
###begin article-title 195
Activated Ras signals differentiation and expansion of CD4+8+ thymocytes
###end article-title 195
###begin article-title 196
###xml 23 28 <span type="species:ncbi:9606">human</span>
NRAS mutation causes a human autoimmune lymphoproliferative syndrome
###end article-title 196
###begin article-title 197
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
###end article-title 197
###begin article-title 198
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Notch-1 mutations are secondary events in some patients with T-cell acute lymphoblastic leukemia
###end article-title 198
###begin article-title 199
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
###end article-title 199
###begin article-title 200
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
###end article-title 200
###begin article-title 201
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
###end article-title 201
###begin article-title 202
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
###end article-title 202
###begin article-title 203
Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo
###end article-title 203
###begin article-title 204
###xml 28 34 <span type="species:ncbi:9606">humans</span>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
Ductal pancreatic cancer in humans and mice
###end article-title 204
###begin article-title 205
Genetic alterations during colorectal-tumor development
###end article-title 205
###begin article-title 206
A genetic model for colorectal tumorigenesis
###end article-title 206
###begin article-title 207
Identification of bronchioalveolar stem cells in normal lung and lung cancer
###end article-title 207
###begin article-title 208
Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy
###end article-title 208
###begin article-title 209
Detection of cell cycle subcompartments by flow cytometric estimation of DNA-RNA content in combination with dual-color immunofluorescence
###end article-title 209
###begin article-title 210
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
The total marrow mass of the mouse: a simplified method of measurement
###end article-title 210
###begin p 211
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. AJS, LSC, MD, HCK, MS, MLH, EP, KS, and BSB conceived and designed the experiments. AJS, LSC, MD, HCK, MLH, and BSB performed the experiments. AJS, LSC, MD, HCK, MS, MLH, KS, and BSB analyzed the data. MD, HCK, MS, MLH, EP, KS, and BSB contributed reagents/materials/analysis tools. AJS, KS, and BSB wrote the paper.
###end p 211
###begin p 212
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This work was supported by National Institutes of Health grants R37 CA72614, U01 CA84221, and K08 CA103868; by a Specialized Center of Research award from the Leukemia and Lymphoma Society (LLS 7019-04); by a translational grant from the V Foundation for Cancer Research; by Concern Foundation; by the Connor Foundation; and by the Frank A. Campini Foundation. MS is supported by a fellowship from Fonds de la recherche en sante du Quebec. MLH is supported by a career development award from the St. Baldrick's Foundation. BSB and EP are Scholars of the American Society of Hematology. AJS is a Medical Fellow of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 212
###begin p 213
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 213

